These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36522160)

  • 1. Where's the Vision? The Importance of Visual Outcomes in Neurologic Disorders: The 2021 H. Houston Merritt Lecture.
    Patil SA; Grossman S; Kenney R; Balcer LJ; Galetta S
    Neurology; 2023 Jan; 100(5):244-253. PubMed ID: 36522160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection.
    Sakai RE; Feller DJ; Galetta KM; Galetta SL; Balcer LJ
    J Neuroophthalmol; 2011 Dec; 31(4):362-73. PubMed ID: 22089500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical coherence tomography versus visual evoked potentials in detecting subclinical visual impairment in multiple sclerosis.
    Grecescu M
    J Med Life; 2014; 7(4):538-41. PubMed ID: 25713617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of optical coherence tomography and infrared oculography in assessing the visual pathway and CNS in multiple sclerosis.
    Coric D; Nij Bijvank JA; van Rijn LJ; Petzold A; Balk LJ
    Neurodegener Dis Manag; 2018 Oct; 8(5):323-335. PubMed ID: 30226111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome measures for research in multiple sclerosis.
    Balcer LJ
    J Neuroophthalmol; 2001 Dec; 21(4):296-301. PubMed ID: 11756863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optic neuritis and the evaluation of visual impairment in multiple sclerosis.
    Bermel RA; Balcer LJ
    Continuum (Minneap Minn); 2013 Aug; 19(4 Multiple Sclerosis):1074-86. PubMed ID: 23917102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vision as a piece of the head trauma puzzle.
    Bell CA; Grossman SN; Balcer LJ; Galetta SL
    Eye (Lond); 2023 Aug; 37(12):2385-2390. PubMed ID: 36801966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trials to clinical use: using vision as a model for multiple sclerosis and beyond.
    Balcer LJ
    J Neuroophthalmol; 2014 Sep; 34 Suppl():S18-23. PubMed ID: 25133966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic tests for concussion: is vision part of the puzzle?
    Ventura RE; Jancuska JM; Balcer LJ; Galetta SL
    J Neuroophthalmol; 2015 Mar; 35(1):73-81. PubMed ID: 25675308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disorders of vision in multiple sclerosis.
    Dhanapalaratnam R; Markoulli M; Krishnan AV
    Clin Exp Optom; 2022 Jan; 105(1):3-12. PubMed ID: 34348598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating loss of visual function in multiple sclerosis as measured by low-contrast letter acuity.
    Balcer LJ; Frohman EM
    Neurology; 2010 Apr; 74 Suppl 3():S16-23. PubMed ID: 20421569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of Visual Outcomes in Clinical Trials for Multiple Sclerosis Disease-Modifying Therapies.
    Nolan RC; Akhand O; Rizzo JR; Galetta SL; Balcer LJ
    J Neuroophthalmol; 2018 Jun; 38(2):202-209. PubMed ID: 29750734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Color vision is strongly associated with retinal thinning in multiple sclerosis.
    Villoslada P; Cuneo A; Gelfand J; Hauser SL; Green A
    Mult Scler; 2012 Jul; 18(7):991-9. PubMed ID: 22291035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vision Disturbances in Multiple Sclerosis.
    Costello F
    Semin Neurol; 2016 Apr; 36(2):185-95. PubMed ID: 27116725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative visual tests after poorly recovered optic neuritis due to multiple sclerosis.
    Longbrake EE; Lancia S; Tutlam N; Trinkaus K; Naismith RT
    Mult Scler Relat Disord; 2016 Nov; 10():198-203. PubMed ID: 27919490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe structural and functional visual system damage leads to profound loss of vision-related quality of life in patients with neuromyelitis optica spectrum disorders.
    Schmidt F; Zimmermann H; Mikolajczak J; Oertel FC; Pache F; Weinhold M; Schinzel J; Bellmann-Strobl J; Ruprecht K; Paul F; Brandt AU
    Mult Scler Relat Disord; 2017 Jan; 11():45-50. PubMed ID: 28104256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of vision restoration therapy after optic neuritis (VISION study): study protocol for a randomized controlled trial.
    Schinzel J; Schwarzlose L; Dietze H; Bartusch K; Weiss S; Ohlraun S; Paul F; Dörr J
    Trials; 2012 Jun; 13():94. PubMed ID: 22742888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The King-Devick (K-D) test of rapid eye movements: a bedside correlate of disability and quality of life in MS.
    Moster S; Wilson JA; Galetta SL; Balcer LJ
    J Neurol Sci; 2014 Aug; 343(1-2):105-9. PubMed ID: 24954088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent visual impairment in multiple sclerosis: prevalence, mechanisms and resulting disability.
    Jasse L; Vukusic S; Durand-Dubief F; Vartin C; Piras C; Bernard M; Pélisson D; Confavreux C; Vighetto A; Tilikete C
    Mult Scler; 2013 Oct; 19(12):1618-26. PubMed ID: 23462348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between Visual Dysfunction and Retinal Changes in Patients with Multiple Sclerosis.
    Satue M; Rodrigo MJ; Otin S; Bambo MP; Fuertes MI; Ara JR; Martin J; Polo V; Larrosa JM; Pablo L; Garcia-Martin E
    PLoS One; 2016; 11(6):e0157293. PubMed ID: 27351450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.